New Jersey A3093 mandates hospitals to inform breast cancer patients about reconstructive surgery options and restricts managed care plan contracts.

New Jersey A3093 requires hospitals to provide breast cancer patients with written information about reconstructive surgery options, including consultations with board-certified plastic surgeons. This information must be given upon diagnosis and before surgical consent. The bill also prohibits managed care plan contracts from limiting health care providers' recommendations for reconstructive surgery based on network affiliation. Carriers are barred from denying reconstructive surgery approvals based on the surgeon's network status or hospital affiliation.

New Jersey A3093 mandates hospitals to inform breast cancer patients about reconstructive surgery options and restricts managed care plan contracts.

New Jersey A3093 requires hospitals to provide breast cancer patients with written information about reconstructive surgery options, including consultations with board-certified plastic surgeons. This information must be given upon diagnosis and before surgical consent. The bill also prohibits managed care plan contracts from limiting health care providers' recommendations for reconstructive surgery based on network affiliation. Carriers are barred from denying reconstructive surgery approvals based on the surgeon's network status or hospital affiliation.